Found: 169
Select item for more details and to access through your institution.
Aprocitentan: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 7, p. 841, doi. 10.1007/s40265-024-02053-0
- By:
- Publication type:
- Article
Ticagrelor: A Review of Its Use in Adults with Acute Coronary Syndromes.
- Published in:
- American Journal of Cardiovascular Drugs, 2015, v. 15, n. 1, p. 51, doi. 10.1007/s40256-015-0108-5
- By:
- Publication type:
- Article
Omega-3 Carboxylic Acids (Epanova): A Review of Its Use in Patients with Severe Hypertriglyceridemia.
- Published in:
- American Journal of Cardiovascular Drugs, 2014, v. 14, n. 5, p. 393, doi. 10.1007/s40256-014-0090-3
- By:
- Publication type:
- Article
Bosentan: A Review of its Use in the Management of Mildly Symptomatic Pulmonary Arterial Hypertension.
- Published in:
- American Journal of Cardiovascular Drugs, 2009, v. 9, n. 5, p. 331, doi. 10.2165/11202270-000000000-00000
- By:
- Publication type:
- Article
Argatroban: A Review of its Use in the Management of Heparin-Induced Thrombocytopenia.
- Published in:
- American Journal of Cardiovascular Drugs, 2009, v. 9, n. 4, p. 261, doi. 10.2165/1120090-000000000-00000
- By:
- Publication type:
- Article
Correction to: Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 2, p. 221, doi. 10.1007/s40261-018-0741-2
- By:
- Publication type:
- Article
Correction to: Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 2, p. 221, doi. 10.1007/s40261-018-0741-2
- By:
- Publication type:
- Article
Hydrocodone Bitartrate ER (Hysingla ER): A Review in Chronic Pain.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 11, p. 969, doi. 10.1007/s40261-016-0466-z
- By:
- Publication type:
- Article
Zevorcabtagene Autoleucel: First Approval.
- Published in:
- Molecular Diagnosis & Therapy, 2024, v. 28, n. 4, p. 501, doi. 10.1007/s40291-024-00723-z
- By:
- Publication type:
- Article
Epi proColon 2.0 CE: A Blood-Based Screening Test for Colorectal Cancer.
- Published in:
- Molecular Diagnosis & Therapy, 2017, v. 21, n. 2, p. 225, doi. 10.1007/s40291-017-0259-y
- By:
- Publication type:
- Article
Correction: Tegileridine: First Approval.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Tarlatamab: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 8, p. 995, doi. 10.1007/s40265-024-02070-z
- By:
- Publication type:
- Article
Tovorafenib: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 8, p. 985, doi. 10.1007/s40265-024-02069-6
- By:
- Publication type:
- Article
Tegileridine: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 6, p. 717, doi. 10.1007/s40265-024-02033-4
- By:
- Publication type:
- Article
Crovalimab: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 6, p. 707, doi. 10.1007/s40265-024-02032-5
- By:
- Publication type:
- Article
Correction: Aponermin: First Approval.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Fidanacogene Elaparvovec: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 4, p. 479, doi. 10.1007/s40265-024-02017-4
- By:
- Publication type:
- Article
Aponermin: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 4, p. 459, doi. 10.1007/s40265-024-02004-9
- By:
- Publication type:
- Article
Repotrectinib: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 2, p. 239, doi. 10.1007/s40265-023-01990-6
- By:
- Publication type:
- Article
Narlumosbart: First Approval.
- Published in:
- Drugs, 2024, v. 84, n. 1, p. 105, doi. 10.1007/s40265-023-01985-3
- By:
- Publication type:
- Article
Sunvozertinib: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 17, p. 1629, doi. 10.1007/s40265-023-01959-5
- By:
- Publication type:
- Article
Elranatamab: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 17, p. 1621, doi. 10.1007/s40265-023-01954-w
- By:
- Publication type:
- Article
Beremagene Geperpavec: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 12, p. 1131, doi. 10.1007/s40265-023-01921-5
- By:
- Publication type:
- Article
Correction to: Zavegepant: First Approval.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Zavegepant: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 9, p. 825, doi. 10.1007/s40265-023-01885-6
- By:
- Publication type:
- Article
Adagrasib: First Approval.
- Published in:
- Drugs, 2023, v. 83, n. 3, p. 275, doi. 10.1007/s40265-023-01839-y
- By:
- Publication type:
- Article
Pucotenlimab: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 15, p. 1557, doi. 10.1007/s40265-022-01787-z
- By:
- Publication type:
- Article
Desidustat: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 11, p. 1207, doi. 10.1007/s40265-022-01744-w
- By:
- Publication type:
- Article
Sutimlimab: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 7, p. 817, doi. 10.1007/s40265-022-01711-5
- By:
- Publication type:
- Article
Tebentafusp: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 6, p. 703, doi. 10.1007/s40265-022-01704-4
- By:
- Publication type:
- Article
Sugemalimab: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 5, p. 593, doi. 10.1007/s40265-022-01693-4
- By:
- Publication type:
- Article
Olverembatinib: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 4, p. 469, doi. 10.1007/s40265-022-01680-9
- By:
- Publication type:
- Article
Penpulimab: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 18, p. 2159, doi. 10.1007/s40265-021-01640-9
- By:
- Publication type:
- Article
Avalglucosidase alfa: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 15, p. 1803, doi. 10.1007/s40265-021-01600-3
- By:
- Publication type:
- Article
Telitacicept: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 14, p. 1671, doi. 10.1007/s40265-021-01591-1
- By:
- Publication type:
- Article
Correction to: Aducanumab: First Approval.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Aducanumab: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 12, p. 1437, doi. 10.1007/s40265-021-01569-z
- By:
- Publication type:
- Article
Correction to: Lazertinib: First Approval.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Lazertinib: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 9, p. 1107, doi. 10.1007/s40265-021-01533-x
- By:
- Publication type:
- Article
Melphalan Flufenamide (Melflufen): First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 8, p. 963, doi. 10.1007/s40265-021-01522-0
- By:
- Publication type:
- Article
Trilaciclib: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 7, p. 867, doi. 10.1007/s40265-021-01508-y
- By:
- Publication type:
- Article
Umbralisib: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 7, p. 857, doi. 10.1007/s40265-021-01504-2
- By:
- Publication type:
- Article
Correction to: Lonafarnib: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 5, p. 619, doi. 10.1007/s40265-021-01500-6
- By:
- Publication type:
- Article
Orelabrutinib: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 4, p. 503, doi. 10.1007/s40265-021-01482-5
- By:
- Publication type:
- Article
Correction to: Filgotinib: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 2, p. 297, doi. 10.1007/s40265-021-01468-3
- By:
- Publication type:
- Article
Lonafarnib: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 2, p. 283, doi. 10.1007/s40265-020-01464-z
- By:
- Publication type:
- Article
Correction to: Decitabine/Cedazuridine: First Approval.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Filgotinib: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 18, p. 1987, doi. 10.1007/s40265-020-01439-0
- By:
- Publication type:
- Article